Court approves fire sale of most of Rite Aid’s pharmacy assets

Published 05/21/2025, 03:48 PM
Updated 05/21/2025, 04:47 PM
© Reuters. FILE PHOTO: A woman shops inside of a Rite Aid store underneath a DeepCam security camera in New York City, New York, U.S., June 25, 2020. Picture taken June 25, 2020. REUTERS/Lucas Jackson/File photo

By Sabrina Valle and Dietrich Knauth

(Reuters) -Bankrupt Rite Aid (NYSE:US90274J5618=UBSS) on Wednesday received court approval to close stores and sell most of its pharmacy assets in separate transactions to CVS, Walgreens, Albertsons (NYSE:ACI), Kroger (NYSE:KR) and Giant Eagle, among others. 

The U.S. pharmacy chain, which operates about 1,200 stores and has some 8 million customers, filed for bankruptcy earlier this month for the second time in two years. Its retail business was performing poorly due to decreased drug sales margins.

U.S. Bankruptcy Judge Michael Kaplan approved a fire sale for the assets Rite Aid had found buyers for in a court hearing in Trenton, New Jersey, prioritizing the transfer of prescription services for its customers over store landlords. 

The sale price has not been disclosed.

Rite Aid said it will sell customer prescription files to 13 buyers, including CVS , Walgreens , Albertsons , and Kroger . Rite Aid’s attorney Alice Eaton (NYSE:ETN) said the quick transfer of pharmacy customers’ prescription files accomplished one of the company’s primary goals in bankruptcy.

Rite Aid has buyers for customer files at 810 of its stores, but failed to locate buyers for the files at 200 others, Eaton said. CVS is the largest buyer, and has also agreed to acquire 64 store locations in addition to taking over prescriptions for Rite Aid customers at 650 other locations.

Shmuel Klein, an attorney who represents three Rite Aid landlords, objected to the sale, saying that Rite Aid should disclose who bought what and for how much, so that landlords know how the bankruptcy will affect their lease payments.

"We still don’t know what leases were bought," Klein said. "It’s not even half baked - it’s sort of a raw hamburger we’re getting served here."

Judge Kaplan overruled the request, saying the public interest in ensuring the transfer of prescriptions from one pharmacy facility to another was of utmost importance.

"I think you would agree I cannot delay or defer that process to address specific landlord issues," Kaplan said.

The Pennsylvania-based company entered bankruptcy with over $2 billion in debt, and it warned employees about likely job cuts earlier this month. 

Rite Aid had previously filed for Chapter 11 protection in October 2023 after reporting $750 million in losses for the previous fiscal year. 

The company used its previous bankruptcy to cut $2 billion in debt, close hundreds of stores, sell its pharmacy benefit company Elixir, and negotiate settlements with its lenders, drug distribution partner McKesson (NYSE:MCK) and municipalities that had sued Rite Aid for allegedly filling suspicious prescriptions for addictive opioid drugs. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.